Market capitalization | $1.19b |
Enterprise Value | $1.35b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 8.79 |
P/S ratio (TTM) P/S ratio | 7.75 |
P/B ratio (TTM) P/B ratio | 39.27 |
Revenue growth (TTM) Revenue growth | -13.72% |
Revenue (TTM) Revenue | $153.07m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
7 Analysts have issued a Establishment Labs Holdings, Inc. forecast:
7 Analysts have issued a Establishment Labs Holdings, Inc. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 153 153 |
14%
14%
|
|
Gross Profit | 100 100 |
13%
13%
|
|
EBITDA | -47 -47 |
11%
11%
|
EBIT (Operating Income) EBIT | -53 -53 |
5%
5%
|
Net Profit | -71 -71 |
1%
1%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Establishment Labs Holdings, Inc. engages in the design, development, manufacture, and marketing of silicone breast implants. It offers its products under Motiva Implants brand. The company was founded by Juan Jose Chacon-Quiros in 2013 and is headquartered in Alajuela, Costa Rica.
Head office | Virgin Islands, British |
CEO | Juan Chacón-Quirós |
Employees | 908 |
Founded | 2004 |
Website | www.establishmentlabs.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.